Ontology highlight
ABSTRACT: Introduction
Papillary Glioneuronal Tumor (PGNT) is a grade I tumor which was classified as a separate entity in the World Health Organization Classification of the Central Nervous System 2007 in the group of mixed glioneuronal tumors. This tumor is rare and subclassifying PGNT represents a challenge. Recently, a fusion between SLC44A1 and PRKCA which encodes a protein kinase C involved in MAPK signaling pathway has been described in two studies (five cases). The current study aimed at raising the cytogenetic, histological and molecular profiles of PGNT and to determine if SLC44A1-PRKCA fusion represented a specific diagnostic marker to distinguish it from other glioneuronal tumors.Results
We report on four pediatric cases of PGNT, along with clinico-radiologic and immunohi
SUBMITTER: Pages M
PROVIDER: S-EPMC4681033 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature